A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease鈥攁 leading cause of death in the United States.
Analysis by University of Adelaide researchers has found that claims about sustainability are increasing in agricultural genomics research, but the term is often not well-defined, leading to potential concerns about the impact and credibility of the research.
Researchers from the U.S. Department of Energy鈥檚 (DOE) Brookhaven National Laboratory and DOE鈥檚 Pacific Northwest National Laboratory (PNNL) have uncovered an unexpected interface layer that may be hindering the performance of superconducting qubits, the building blocks of quantum computers. While examining this layer through a combination of imaging techniques and theoretical models, they discovered the underlying cause of puzzling structural differences in qubits.
People living with HIV are less likely to receive potentially lifesaving cancer treatment if they live in communities with lower income levels and educational attainment, according to a new national study led by researchers from Moffitt Cancer Center.
Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug Administration (FDA) approved effective new weight-loss medications for this age group, a study led by UT Southwestern Medical Center researchers shows.
Weight loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across pop culture and scientific sectors alike. But it appears that hearing about these medications is a lot easier than actually getting them.
Yale researchers have built a 3D-bioprinted synthetic aorta that they have successfully implanted into rats. This technology could advance the treatment of cardiovascular diseases such as coronary artery disease or peripheral arterial disease by allowing scientists to engineer and replace blood vessels in humans.
Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease.
A breast cancer surgeon and director of the Hispanic Breast Cancer Program at Smilow Cancer Hospital at Fairfield/Bridgeport, Dr. Monica Valero also sees patients at Smilow Cancer Hospital at New Haven and Trumbull. Before joining the Yale Cancer Center and Smilow, Dr. Valero was on faculty at Beth Israel Deaconess Medical Center.